Abstracts

CYTOMEGALOVIRUS VIREMIA AS A RISK FACTOR FOR MORTALITY IN HIV-ASSOCIATED MENINGITIS

Cytomegalovirus (CMV) viremia is associated with increased mortality in persons with HIV. We previously demonstrated that CMV viremia was a risk factor for 10-week mortality in antiretroviral therapy (ART)-naïve persons with cryptococcal meningitis. We investigated whether similar observations existed over a broader cohort of HIV-associated meningitis. We prospectively enrolled Ugandans with cryptococcal or tuberculous (TB)…

RIFABUTIN FORMULATION THAT DELIVERS DRUG 4 MONTHS PREVENTS AND TREATS Mtb INFECTION

Tuberculosis (TB) is a major cause of morbidity and mortality worldwide for people living with HIV. Rifabutin (RFB) is an anti-TB drug with potent anti-bactericidal activity, low minimum inhibitory concentration (MIC, 64 ng/ml), long terminal half-life, higher tissue uptake and reduced potential for drug-drug interactions compared to other TB drugs from the rifamycin family. Successful…

MODELING THE IMPACT OF HIV AND TB INTERVENTIONS ON SOUTH AFRICAN TB TRENDS: 1990-2019

The South African tuberculosis (TB) epidemic is largely driven by HIV. Interventions including directly observed therapy (DOTS), antiretroviral therapy (ART), isoniazid preventative therapy (IPT), increased TB screening, and Xpert MTB/RIF have been implemented to reduce TB incidence and mortality. This study aimed to estimate the impact of HIV and interventions on the South African TB…

CLINICAL AND LABORATORY PREDICTORS OF TUBERCULOSIS RECURRENCE

Despite successful completion of therapy for drug-susceptible pulmonary tuberculosis (PTB), a subset of individuals experience an unfavorable treatment outcome of tuberculosis (TB) recurrence. India accounts for 26% of the global burden of TB and few data on predictors of TB recurrence exist, especially with a focus on India. A TB recurrence prediction model could enable…